RecruitingNot ApplicableNCT05112328
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding: Prospective Randomized Controlled Trial
Sponsor
Seoul National University Hospital
Enrollment
170 participants
Start Date
Jul 7, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
Determine the effect of high-dose pancreatic enzyme supplementation on nutritional indicators and clinical course in critically ill patients undergoing enteral nutrition.
Eligibility
Min Age: 18 Years
Inclusion Criteria12
- Adults 19 years and older
- Hospitalized in the surgical/medical intensive care unit of the Seoul National University Hospital
- Enteral nutrition
- Patients who consented to this study
- Patients with risk factors for pancreatic exocrine dysfunction
- Shock (Norepinephrine)
- Sepsis (3 rd definition of sepsis)
- Diabetes
- Cardiac arrest
- hyperlactatemia serum lactate > 2 mmol/L)
- Mechanical ventilation
- Continuous renal replacement therapy
Exclusion Criteria6
- chronic pancreatitis
- unresectable pancreatic cancer
- History of pancreatectomy
- Underlying diseases in which the effect of Exocrine pancreatic enzyme administration is difficult to show
- Inflammatory bowel disease
- Short bowel syndrome
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGExocrine Pancreatic Enzyme
Pancreatic enzyme supplementation for critically ill patients on enteral nutrition
DRUGPlacebo
Placebo of Pancreatic enzyme for critically ill patients on enteral nutrition
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05112328
Related Trials
A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects
NCT072858631 location
Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis
NCT074185932 locations
Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients
NCT072220071 location
Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
NCT057103151 location
Feasibility of End-tidal Oxygen Concentration Monitoring During Preoxygenation for Intubation in the Intensive Care Unit.
NCT054095731 location